Creutzfeldt-Jakob disease: therapeutic strategies

Author： Beringue V. Deslys J-P. Adjou K.T. Dormont D.

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.6, Iss.4, 1997-04, pp. : 345-348

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic approaches in treating Creutzfeldt-Jakob disease – what does the future hold?

By Croes Esther A

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2391-2396

Informa Healthcare

Access to resources Recommend Favorite

Somatropin: Creutzfeldt-Jakob disease: case report

Reactions Weekly, Vol. 1, Iss. 1196, 2008-01 ,pp. : 34-35

Adis International

Access to resources Recommend Favorite

Is there a real risk of transmitting variant Creutzfeldt–Jakob disease by donor sperm insemination?

By Mortimer D Barratt CLR

Reproductive BioMedicine Online, Vol. 13, Iss. 6, 2006-12 ,pp. : 778-790

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Possible Editing of Alu Transcripts in Blood Cells of Sporadic Creutzfeldt-Jakob Disease (sCJD)

By Kiesel Petra Gibson Toby Ciesielczyk Barbara Bodemer Monika Kaup Franz-Josef Bodemer Walter Zischler Hans Zerr Inga

Journal of Toxicology and Environmental Health, Vol. 74, Iss. 2-4, 2011-01 ,pp. : 88-95

Taylor & Francis Ltd

Access to resources Recommend Favorite

Homozygosity at prion protein gene codon 129 increases somatropin-transmitted Creutzfeldt-Jakob disease (CJD) risk

Inpharma, Vol. 1, Iss. 1396, 2003-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite